Hashiguchi Takao, Kajikawa Mizuho, Maita Nobuo, Takeda Makoto, Kuroki Kimiko, Sasaki Kaori, Kohda Daisuke, Yanagi Yusuke, Maenaka Katsumi
Department of Virology, Faculty of Medicine, and Division of Structural Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan.
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19535-40. doi: 10.1073/pnas.0707830104. Epub 2007 Nov 14.
Measles still remains a major cause of childhood morbidity and mortality worldwide. Measles virus (MV) vaccines are highly successful, but the mechanism underlying their efficacy has been unclear. Here we report the crystal structure of the MV attachment protein, hemagglutinin, responsible for MV entry. The receptor-binding head domain exhibits a cubic-shaped beta-propeller structure and forms a homodimer. N-linked sugars appear to mask the broad regions and cause the two molecules forming the dimer to tilt oppositely toward the horizontal plane. Accordingly, residues of the putative receptor-binding site, highly conserved among MV strains, are strategically positioned in the unshielded area of the protein. These conserved residues also serve as epitopes for neutralizing antibodies, ensuring the serological monotype, a basis for effective MV vaccines. Our findings suggest that sugar moieties in the MV hemagglutinin critically modulate virus-receptor interaction as well as antiviral antibody responses, differently from sugars of the HIV gp120, which allow for immune evasion.
麻疹仍然是全球儿童发病和死亡的主要原因。麻疹病毒(MV)疫苗非常成功,但其有效性背后的机制尚不清楚。在此,我们报告了负责MV进入的附着蛋白血凝素的晶体结构。受体结合头部结构域呈现立方体形的β-螺旋桨结构并形成同型二聚体。N-连接糖似乎掩盖了广泛区域,并导致形成二聚体的两个分子向水平面相反方向倾斜。因此,在MV毒株中高度保守的假定受体结合位点的残基,战略性地定位在蛋白质的未屏蔽区域。这些保守残基还作为中和抗体的表位,确保血清学单一型,这是有效MV疫苗的基础。我们的研究结果表明,MV血凝素中的糖部分关键地调节病毒-受体相互作用以及抗病毒抗体反应,这与HIV gp120的糖不同,后者允许免疫逃逸。